EU Director, AI-Driven Pharma Business Development
Waiv, formerly Owkin Dxparis, île- e france, FranceWaiv, a spin-out of Owkin, exists to catalyze precision medicine with clinical-grade, AI-powered tests that accelerate biomarker discovery and detection, outcome prediction, and treatment-response ... Voir plus